SEC Form SC 13G/A filed by NewAmsterdam Pharma Company N.V. (Amendment)

2/14/24 10:12:30 AM ET

$NAMS

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $NAMS alert in real time by email

SC 13G/A 1 sayw24021414_13ga.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-

1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2

UNDER THE SECURITIES EXCHANGE ACT OF 1934*

(Amendment No. 1)

NewAmsterdam Pharma Company N.V.

(Name of Issuer)

Ordinary shares, nominal value €0.12 per share

(Title of Class of Securities)

N62509109

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. N62509109

13G

Page 2 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Viking Global Investors LP

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			8,024,565*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			8,024,565*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	8,024,565*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	9.7%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

* See Item 4

CUSIP No. N62509109

13G

Page 3 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Viking Global Opportunities Parent GP LLC

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			8,024,565*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			8,024,565*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	8,024,565*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	9.7%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

* See Item 4

CUSIP No. N62509109

13G

Page 4 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Viking Global Opportunities GP LLC

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			5,376,459*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			5,376,459*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	5,376,459*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	6.5%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

* See Item 4

CUSIP No. N62509109

13G

Page 5 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Viking Global Opportunities Portfolio GP LLC

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			5,376,459*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			5,376,459*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	5,376,459*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	6.5%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

* See Item 4

CUSIP No. N62509109

13G

Page 6 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Viking Global Opportunities Illiquid Investments Sub-Master LP

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			5,376,459*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			5,376,459*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	5,376,459*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	6.5%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

* See Item 4

CUSIP No. N62509109

13G

Page 7 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Viking Global Opportunities Drawdown GP LLC

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			2,648,106*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			2,648,106*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,648,106*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	3.2%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

* See Item 4

CUSIP No. N62509109

13G

Page 8 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Viking Global Opportunities Drawdown Portfolio GP LLC

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			2,648,106*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			2,648,106*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,648,106*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	3.2%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

* See Item 4

CUSIP No. N62509109

13G

Page 9 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Viking Global Opportunities Drawdown (Aggregator) LP

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Cayman Islands

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			2,648,106*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			2,648,106*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	2,648,106*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	3.2%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	PN

* See Item 4

CUSIP No. N62509109

13G

Page 10 of 20 Pages

1	NAMES OF REPORTING PERSONS
	O. Andreas Halvorsen

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Norway

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			8,024,565*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			8,024,565*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	8,024,565*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	9.7%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IN

* See Item 4

CUSIP No. N62509109

13G

Page 11 of 20 Pages

1	NAMES OF REPORTING PERSONS
	David C. Ott

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			8,024,565*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			8,024,565*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	8,024,565*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	9.7%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IN

* See Item 4

CUSIP No. N62509109

13G

Page 12 of 20 Pages

1	NAMES OF REPORTING PERSONS
	Rose S. Shabet

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(a)☐
	(b)☒
3	SEC USE ONLY


4	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER
			0

		6	SHARED VOTING POWER
			8,024,565*

		7	SOLE DISPOSITIVE POWER
			0

		8	SHARED DISPOSITIVE POWER
			8,024,565*

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	8,024,565*

10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	☐

11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	9.7%*

12	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IN

* See Item 4

CUSIP No. N62509109

13G

Page 13 of 20 Pages

Item 1(a).

Name of Issuer:

NewAmsterdam Pharma Company N.V.

Item 1(b).

Address of Issuer’s Principal Executive Offices:

Gooimeer 2-35, 1411 DC Naarden, The Netherlands

Item 2(a).

Name of Person Filing:

Viking Global Investors LP (“VGI”),

Viking Global Opportunities Parent GP LLC (“Opportunities Parent”),

Viking Global Opportunities GP LLC (“Opportunities GP”),

Viking Global Opportunities Portfolio GP LLC (“Opportunities Portfolio GP”),

Viking Global Opportunities Illiquid Investments Sub-Master LP (“VGOP”),

Viking Global Opportunities Drawdown GP LLC (“VGOD GP”),

Viking Global Opportunities Drawdown Portfolio GP LLC (“VGOD Portfolio GP”),

Viking Global Opportunities Drawdown (Aggregator) LP (“VGOD”),

O. Andreas Halvorsen, David C. Ott and Rose S. Shabet (collectively, the “Reporting Persons”).

Item 2(b).

Address of Principal Business Office or, if none, Residence:

The business address of each of the Reporting Persons is: 600 Washington Boulevard, Floor 11, Stamford, Connecticut 06901.

Item 2(c).

Citizenship:

VGI is a Delaware limited partnership; Opportunities Parent, Opportunities GP, Opportunities Portfolio GP, VGOD GP, and VGOD Portfolio GP are Delaware limited liability companies; VGOP and VGOD are Cayman Islands exempted limited partnerships; O. Andreas Halvorsen is a citizen of Norway; and David C. Ott and Rose S. Shabet are citizens of the United States.

Item 2(d).

Titles of Classes of Securities:

Ordinary shares, nominal value €0.12 per share (“Ordinary Shares”)

Item 2(e).

CUSIP NUMBER: N62509109

Item 3.

If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

(a)

☐ Broker or dealer registered under Section 15 of the Exchange Act

(b)

☐ Bank as defined in Section 3(a)(6) of the Exchange Act

(c)

☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act

(d)

☐ Investment company registered under Section 8 of the Investment Company Act of 1940

(e)

☐ Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940: see Rule 13d-1(b)(1)(ii)(E)

(f)

☐ Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F)

(g)

☐ Parent holding company, in accordance with Rule 13d-1(b)(1)(ii)(G).

(h)

☐ Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act.

(i)

☐ Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940.

CUSIP No. N62509109

13G

Page 14 of 20 Pages

(j)

☐ Non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k)

☐ Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership:

The percentages set forth herein are calculated based on 82,469,768 Ordinary Shares outstanding prior to the Issuer's issuance of Ordinary Shares underlying options issued pursuant to the Issuer's Rollover Option Plan, as reported in the Issuer’s prospectus on Form 424B3, filed with the Securities and Exchange Commission (the “Commission”) on August 15, 2023.

VGI

(a)

Amount beneficially owned: 8,024,565

(b)

Percent of Class: 9.7%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 8,024,565

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 8,024,565

VGI provides managerial services to VGOP and VGOD. VGI has the authority to dispose of and vote the Ordinary Shares that VGOP and VGOD directly own. VGI does not directly own any Ordinary Shares.

Based on Rule 13d-3 of the Act, VGI may be deemed to beneficially own the Ordinary Shares that VGOP and VGOD directly own.

VGI beneficially owns 8,024,565 Ordinary Shares consisting of 5,376,459 and 2,648,106 Ordinary Shares directly owned by VGOP and VGOD, respectively.

Opportunities Parent

(a)

Amount beneficially owned: 8,024,565

(b)

Percent of Class: 9.7%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 8,024,565

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 8,024,565

Opportunities Parent is the sole member of Opportunities GP, which has the authority to dispose of and vote the Ordinary Shares controlled by Opportunities Portfolio GP (which consists of the Ordinary Shares that VGOP directly owns), and is the sole member of VGOD GP, which has the authority to dispose of and vote the Ordinary Shares controlled by VGOD Portfolio GP (which consists of the Ordinary Shares that VGOD directly owns). Opportunities Parent does not directly own any Ordinary Shares.

CUSIP No. N62509109

13G

Page 15 of 20 Pages

Based on Rule 13d-3 of the Act, Opportunities Parent may be deemed to beneficially own the Ordinary Shares that VGOP and VGOD directly own.

Opportunities Parent beneficially owns 8,024,565 Ordinary Shares consisting of 5,376,459 and 2,648,106 Ordinary Shares directly owned by VGOP and VGOD, respectively.

Opportunities GP

(a)

Amount beneficially owned: 5,376,459

(b)

Percent of Class: 6.5%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 5,376,459

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 5,376,459

Opportunities GP serves as the sole member of Opportunities Portfolio GP and has the authority to dispose of and vote the Ordinary Shares controlled by Opportunities Portfolio GP, which consists of the Ordinary Shares that VGOP directly owns. In addition, Opportunities GP is the general partner of each of Viking Global Opportunities Intermediate LP, Viking Global Opportunities III LP, and Viking Global Opportunities LP. Opportunities GP does not directly own any Ordinary Shares.

Based on Rule 13d-3 of the Act, Opportunities GP may be deemed to beneficially own the Ordinary Shares that VGOP directly owns.

Opportunities GP beneficially owns 5,376,459 Ordinary Shares consisting of 5,376,459 Ordinary Shares directly owned by VGOP.

Opportunities Portfolio GP

(a)

Amount beneficially owned: 5,376,459

(b)

Percent of Class: 6.5%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 5,376,459

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 5,376,459

CUSIP No. N62509109

13G

Page 16 of 20 Pages

Opportunities Portfolio GP serves as the general partner of VGOP and has the authority to dispose of and vote the Ordinary Shares that VGOP directly owns. Opportunities Portfolio GP does not directly own any Ordinary Shares.

Based on Rule 13d-3 of the Act, Opportunities Portfolio GP may be deemed to beneficially own the Ordinary Shares that VGOP directly owns.

Opportunities Portfolio GP beneficially owns 5,376,459 Ordinary Shares consisting of 5,376,459 Ordinary Shares directly owned by VGOP.

VGOP

(a)

Amount beneficially owned: 5,376,459

(b)

Percent of Class: 6.5%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 5,376,459

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 5,376,459

VGOP has the authority to dispose of and vote the 5,376,459 Ordinary Shares that it directly owns, which power may be exercised by its general partner, Opportunities Portfolio GP, and by VGI, an affiliate of Opportunities Portfolio GP, which provides managerial services to VGOP.

Viking Global Opportunities LP (a Delaware limited partnership) and Viking Global Opportunities III LP (a Cayman Islands exempted limited partnership), through its investment in Viking Global Opportunities Intermediate LP (a Cayman Islands exempted limited partnership), invest substantially all of their assets in Viking Global Opportunities Master LP (a Cayman Islands exempted limited partnership), which in turn invests through VGOP.

VGOD GP

(a)

Amount beneficially owned: 2,648,106

(b)

Percent of Class: 3.2%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 2,648,106

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 2,648,106

CUSIP No. N62509109

13G

Page 17 of 20 Pages

VGOD GP serves as the sole member of VGOD Portfolio GP and has the authority to dispose of and vote the Ordinary Shares controlled by VGOD Portfolio GP, which consists of the Ordinary Shares that VGOD directly owns. In addition, VGOD GP is the general partner of each of Viking Global Opportunities Drawdown (Internal) LP, Viking Global Opportunities Drawdown (Onshore) LP, and Viking Global Opportunities Drawdown (Offshore) LP. VGOD GP does not directly own any Ordinary Shares.

Based on Rule 13d-3 of the Act, VGOD GP may be deemed to beneficially own the Ordinary Shares that VGOD directly owns.

VGOD GP beneficially owns 2,648,106 Ordinary Shares consisting of 2,648,106 Ordinary Shares directly owned by VGOD.

VGOD Portfolio GP

(a)

Amount beneficially owned: 2,648,106

(b)

Percent of Class: 3.2%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 2,648,106

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 2,648,106

VGOD Portfolio GP serves as the general partner of VGOD and has the authority to dispose of and vote the Ordinary Shares that VGOD directly owns. VGOD Portfolio GP does not directly own any Ordinary Shares.

Based on Rule 13d-3 of the Act, VGOD Portfolio GP may be deemed to beneficially own the Ordinary Shares that VGOD directly owns.

VGOD Portfolio GP beneficially owns 2,648,106 Ordinary Shares consisting of 2,648,106 Ordinary Shares directly owned by VGOD.

VGOD

(a)

Amount beneficially owned: 2,648,106

(b)

Percent of Class: 3.2%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 2,648,106

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 2,648,106

VGOD has the authority to dispose of and vote the 2,648,106 Ordinary Shares that it directly owns, which power may be exercised by its general partner, VGOD Portfolio GP, and by VGI, an affiliate of VGOD Portfolio GP, which provides managerial services to VGOD.

CUSIP No. N62509109

13G

Page 18 of 20 Pages

Viking Global Opportunities Drawdown (Offshore) LP (a Cayman Islands exempted limited partnership) and Viking Global Opportunities Drawdown (Internal) LP (a Delaware limited partnership), through its investment in Viking Global Opportunities Drawdown (Onshore) LP (a Delaware limited partnership), invest substantially all of their assets in VGOD.

O. Andreas Halvorsen, David C. Ott and Rose S. Shabet

(a)

Amount beneficially owned: 8,024,565

(b)

Percent of Class: 9.7%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 0

(ii)

Shared power to vote or to direct the vote: 8,024,565

(iii)

Sole power to dispose or to direct the disposition of: 0

(iv)

Shared power to dispose or to direct the disposition of: 8,024,565

Mr. Halvorsen, Mr. Ott and Ms. Shabet, as Executive Committee Members of Viking Global Partners LLC (general partner of VGI) and Opportunities Parent, have shared authority to dispose of and vote the Ordinary Shares beneficially owned by VGI and Opportunities Parent. None of Mr. Halvorsen, Mr. Ott and Ms. Shabet directly owns any Ordinary Shares.

Based on Rule 13d-3 of the Act, each may be deemed to beneficially own the Ordinary Shares that VGOP and VGOD directly own.

Each of Mr. Halvorsen, Mr. Ott and Ms. Shabet beneficially owns 8,024,565 Ordinary Shares consisting of 5,376,459 and 2,648,106 Ordinary Shares directly owned by VGOP and VGOD, respectively.

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

The response to Item 4 is incorporated by reference herein.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

Item 8.

Identification and Classification of Members of the Group.

Not applicable.

Item 9.

Notice of Dissolution of Group.

Not applicable.

Item 10.

Certification. (if filing pursuant to Rule 13d-1(c))

By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. N62509109

13G

Page 19 of 20 Pages

SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2024

	By:	/s/ Scott M. Hendler
	Name:	Scott M. Hendler on behalf of O. Andreas Halvorsen (1)

	By:	/s/ Scott M. Hendler
	Name:	Scott M. Hendler on behalf of David C. Ott (2)

	By:	/s/ Scott M. Hendler
	Name:	Scott M. Hendler on behalf of Rose S. Shabet (3)

(1) Scott M. Hendler is signing on behalf of O. Andreas Halvorsen, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737).

(2) Scott M. Hendler is signing on behalf of David C. Ott, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Ott on February 12, 2021 (SEC File No. 005-49737).

(3) Scott M. Hendler is signing on behalf of Rose S. Shabet, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Ms. Shabet on February 12, 2021 (SEC File No. 005-49737).

CUSIP No. N62509109

13G

Page 20 of 20 Pages

EXHIBIT A - JOINT FILING AGREEMENT

This joint filing agreement is made and entered into as of this 14th day of February, 2024, by and among Viking Global Investors LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, Viking Global Opportunities Drawdown GP LLC, Viking Global Opportunities Drawdown Portfolio GP LLC, Viking Global Opportunities Drawdown (Aggregator) LP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.

The parties to this Agreement hereby agree to prepare jointly and file timely (and otherwise to deliver as appropriate) all filings on any Forms 3, 4, or 5 or Schedules 13D or 13G, and any and all amendments thereto and any other documents relating thereto (collectively, the “Filings”) as required to be filed pursuant to the Securities Exchange Act of 1934, as amended. The parties to this Agreement further agree and covenant that each will fully cooperate with such other parties in the preparation, timely filing, and delivery of all such Filings.

IN WITNESS WHEREOF, the parties hereto have executed this agreement as of the date first set forth above.

Dated: February 14, 2024

	By:	/s/ Scott M. Hendler
	Name:	Scott M. Hendler on behalf of O. Andreas Halvorsen (1)

	By:	/s/ Scott M. Hendler
	Name:	Scott M. Hendler on behalf of David C. Ott (2)

	By:	/s/ Scott M. Hendler
	Name:	Scott M. Hendler on behalf of Rose S. Shabet (3)

Get the next $NAMS alert in real time by email

Date	Price Target	Rating	Analyst
12/30/2024	$48.00	Buy	H.C. Wainwright
5/15/2024		Buy	TD Cowen
3/14/2024	$35.00	Sector Outperform	Scotiabank
1/18/2024	$30.00	Buy	Guggenheim
1/16/2024	$37.00	Overweight	Piper Sandler
10/30/2023	$25.00	Outperform	RBC Capital Mkts

SEC Form SC 13G/A filed by NewAmsterdam Pharma Company N.V. (Amendment)

Chat with this insight

Recent Analyst Ratings for
$NAMS

$NAMS
Press Releases

Fastest customizable press release news feed in the world

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors

enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors

$NAMS
SEC Filings

SEC Form DEF 14A filed by NewAmsterdam Pharma Company N.V.

SEC Form 10-Q filed by NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$NAMS
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

$NAMS
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

H.C. Wainwright initiated coverage on NewAmsterdam Pharma with a new price target

TD Cowen initiated coverage on NewAmsterdam Pharma

Scotiabank initiated coverage on NewAmsterdam Pharma with a new price target

$NAMS
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Topper James N bought $25,521 worth of Ordinary Shares (1,135 units at $22.49) (SEC Form 4)

Director Topper James N bought $84,203 worth of Ordinary Shares (4,005 units at $21.02) (SEC Form 4)

Chief Business Officer Audet Juliette Berangere bought $17,333 worth of Ordinary Shares (1,104 units at $15.70) (SEC Form 4)

$NAMS
Leadership Updates

Live Leadership Updates

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors

BioAge Appoints Renowned Cardiologist and Biopharma Entrepreneur Michael H. Davidson, MD, to its Board of Directors

$NAMS
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Officer Audet Juliette Berangere

Director Lange Louis G converted options into 69 units of Ordinary Shares (SEC Form 4)

Director Lange Louis G converted options into 69 units of Ordinary Shares (SEC Form 4)

SEC Form SC 13G/A filed by NewAmsterdam Pharma Company N.V. (Amendment)

Chat with this insight

Recent Analyst Ratings for $NAMS

$NAMS Press Releases

Fastest customizable press release news feed in the world

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors

enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors

$NAMS SEC Filings

SEC Form DEF 14A filed by NewAmsterdam Pharma Company N.V.

SEC Form 10-Q filed by NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$NAMS Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

$NAMS Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

H.C. Wainwright initiated coverage on NewAmsterdam Pharma with a new price target

TD Cowen initiated coverage on NewAmsterdam Pharma

Scotiabank initiated coverage on NewAmsterdam Pharma with a new price target

$NAMS Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Topper James N bought $25,521 worth of Ordinary Shares (1,135 units at $22.49) (SEC Form 4)

Director Topper James N bought $84,203 worth of Ordinary Shares (4,005 units at $21.02) (SEC Form 4)

Chief Business Officer Audet Juliette Berangere bought $17,333 worth of Ordinary Shares (1,104 units at $15.70) (SEC Form 4)

$NAMS Leadership Updates

Live Leadership Updates

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors

BioAge Appoints Renowned Cardiologist and Biopharma Entrepreneur Michael H. Davidson, MD, to its Board of Directors

$NAMS Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Officer Audet Juliette Berangere

Director Lange Louis G converted options into 69 units of Ordinary Shares (SEC Form 4)

Director Lange Louis G converted options into 69 units of Ordinary Shares (SEC Form 4)

Recent Analyst Ratings for
$NAMS

$NAMS
Press Releases

$NAMS
SEC Filings

$NAMS
Large Ownership Changes

$NAMS
Analyst Ratings

$NAMS
Insider Purchases

$NAMS
Leadership Updates

$NAMS
Insider Trading